Multi-Organ Cancer Classification and Survival Analysis
  Accurate and robust cell nuclei classification is the cornerstone for a wider
range of tasks in digital and Computational Pathology. However, most machine
learning systems require extensive labeling from expert pathologists for each
individual problem at hand, with no or limited abilities for knowledge transfer
between datasets and organ sites. In this paper we implement and evaluate a
variety of deep neural network models and model ensembles for nuclei
classification in renal cell cancer (RCC) and prostate cancer (PCa). We propose
a convolutional neural network system based on residual learning which
significantly improves over the state-of-the-art in cell nuclei classification.
Finally, we show that the combination of tissue types during training increases
not only classification accuracy but also overall survival analysis.
